Ratio of spectral averaged cross sections measured in standard

The results of systematic evaluations of spectrum averaged cross section (SACS) measurements in the fission neutron fields of 252Cf and 235U are presented. The data form a complete database of high-threshold experimental SACS measured in the same installation under the same conditions and using the same high purity germanium gamma spectrometer. This is crucial to reduce the uncertainty of the ratio and the data scattering and therefore, to minimize discrepancies compared to cross section measured under different conditions in different laboratories. This new dataset complements and extends earlier experimental evaluations. The total emission of the 252Cf neutron source during the experiments varied from 9.5E8 to 4.5E8 neutrons per second. The emission was derived in accordance to the data in the Certificate of Calibration involving absolute flux measurements in a manganese sulphate bath. Concerning 235U fission neutron field, the irradiations were carried out in a specifically designed core assembled in the zero power light water LR-0 reactor. This special core has a well described neutron field. After the irradiation, the low volume irradiated samples to be measured by gamma spectrometry were placed directly on the upper cap of a coaxial high purity germanium (HPGe) detector in a vertical configuration (ORTEC GEM35P4). High volume samples were homogenized and strewn into the Marinelli beaker. The HPGe detector is surrounded by the lead shielding box with a thin inner copper cladding and covered with rubber for suppression of background signal and bremsstrahlung. The experimental reaction rates were derived for irradiated samples from the Net Peak Areas (NPA) measured using the semiconductor HPGe detector. The measured reaction rates are used to derive the spectrum-averaged cross sections. Furthermore, measured reaction rates are also compared with MCNP6 calculations using various nuclear data libraries, in particular IRDFF evaluations

Ratio of spectral averaged cross sections measured in standard 252Cf(sf) and 235U(nth,f) neutron fields

The results of systematic evaluations of spectrum averaged cross section (SACS) measurements in the fission neutron fields of 252Cf and 235U are presented. The data form a complete database of high-threshold experimental SACS measured in the same installation under the same conditions and using the same high purity germanium gamma spectrometer. This is crucial to reduce the uncertainty of the ratio and the data scattering and therefore, to minimize discrepancies compared to cross section measured under different conditions in different laboratories. This new dataset complements and extends earlier experimental evaluations. The total emission of the 252Cf neutron source during the experiments varied from 9.5E8 to 4.5E8 neutrons per second. The emission was derived in accordance to the data in the Certificate of Calibration involving absolute flux measurements in a manganese sulphate bath. Concerning 235U fission neutron field, the irradiations were carried out in a specifically designed core assembled in the zero power light water LR-0 reactor. This special core has a well described neutron field. After the irradiation, the low volume irradiated samples to be measured by gamma spectrometry were placed directly on the upper cap of a coaxial high purity germanium (HPGe) detector in a vertical configuration (ORTEC GEM35P4). High volume samples were homogenized and strewn into the Marinelli beaker. The HPGe detector is surrounded by the lead shielding box with a thin inner copper cladding and covered with rubber for suppression of background signal and bremsstrahlung. The experimental reaction rates were derived for irradiated samples from the Net Peak Areas (NPA) measured using the semiconductor HPGe detector. The measured reaction rates are used to derive the spectrum-averaged cross sections. Furthermore, measured reaction rates are also compared with MCNP6 calculations using various nuclear data libraries, in particular IRDFF evaluations

Validation of selected (n,2n) dosimetry reactions in IRDFF-1.05 library

Spectrum-averaged cross sections (SACS) have been measured in the reference 252Cf(sf) neutron field for the following high-threshold (n,2n) neutron dosimetry reactions since they are especially important due to the high threshold which allows validation of upper parts of prompt fission neutron spectrum. This work includes 59Co(n,2n)58Co, 197Au(n,2n)196Au, 169Tm(n,2n)168Tm, 55Mn(n,2n)54Mn, 93Nb(n,2n)92 mNb and 89Y(n,2n)88Y and for the 59Co(n,p)59Fe threshold reactions. SACS were inferred from experimentally determined reaction rates by gamma spectrometry using a semiconductor high-purity germanium detector to measure irradiated samples. Measured reaction rates agree within quoted uncertainties with those calculated from the IRDFF-1.05 library, except for the reaction 55Mn(n,2n)54Mn, for which the measured value is underestimated by 16%. For this reaction the ENDF-B/VII.1 evaluation agrees with measured reaction rate within uncertainties.This work has been realized within the SUSEN Project (established in the framework of the European Regional Development Fund (ERDF) in project CZ.1.05/2.1.00/03.0108 and of the European Structural Funds and Investment Funds (ESIF) in the project CZ.02.1.01/0.0/0.0/15_008/ 0000293), which is financially supported by the Ministry of Education, Youth and Sports - project LM2015093 Infrastructure SUSEN

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Background: Venous thromboembolism (VTE), encompassing both deep vein thrombosis (DVT) and pulmonary embolism (PE), is a leading cause of morbidity and mortality worldwide.Methods: GARFIELD-VTE is a prospective, non-interventional observational study of real-world treatment practices. We aimed to capture the 36-month clinical outcomes of 10,679 patients with objectively confirmed VTE enrolled between May 2014 and January 2017 from 415 sites in 28 countries.Findings: A total of 6582 (61.6 %) patients had DVT alone, 4097 (38.4 %) had PE +/- DVT. At baseline, 98.1 % of patients received anticoagulation (AC) with or without other modalities of therapy. The proportion of patients on AC therapy decreased over time: 87.6 % at 3 months, 73.0 % at 6 months, 54.2 % at 12 months and 42.0 % at 36 months. At 12-months follow-up, the incidences (95 % confidence interval [CI]) of all-cause mortality, recurrent VTE and major bleeding were 6.5 (7.0-8.1), 5.4 (4.9-5.9) and 2.7 (2.4-3.0) per 100 person-years, respectively. At 36-months, these decreased to 4.4 (4.2-4.7), 3.5 (3.2-2.7) and 1.4 (1.3-1.6) per 100 person-years, respectively. Over 36-months, the rate of all-cause mortality and major bleeds were highest in patients treated with parenteral therapy (PAR) versus oral anti-coagulants (OAC) and no OAC, and the rate of recurrent VTE was highest in patients on no OAC versus those on PAR and OAC. The most frequent cause of death after 36-month follow-up was cancer (n = 565, 48.6 %), followed by cardiac (n = 94, 8.1 %), and VTE (n = 38, 3.2 %). Most recurrent VTE events were DVT alone (n = 564, 63.3 %), with the remainder PE, (n = 236, 27.3 %), or PE in combination with DVT (n = 63, 7.3 %).Interpretation: GARFIELD-VTE provides a global perspective of anticoagulation patterns and highlights the accumulation of events within the first 12 months after diagnosis. These findings may help identify treatment gaps for subsequent interventions to improve patient outcomes in this patient population